C83.99
Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-follicular (diffuse) lymphoma, unspecified (ICD-10 code C83.99), is a type of cancer that affects the lymphatic system, which is part of the body's immune system. This particular classification refers to lymphomas that do not originate from follicular cells and are characterized by a diffuse growth pattern. When the disease involves outside the lymph nodes, such as in solid organs or other tissues, it is known as extranodal lymphoma. Due to its broad and unspecified classification, understanding this condition focuses on its nature, common locations, and its impact on the body.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocytes (a type of white blood cell) Exposure to certain chemicals or chemicals in workplaces Infections such as Epstein-Barr virus (EBV), Helicobacter pylori, or hepatitis viruses Immune system disorders or suppression, including HIV/AIDS Family history of lymphoma or other lymphoproliferative disorders
Key Symptoms: Swollen lymph nodes that are painless, commonly in the neck, armpits, or groin Unexplained weight loss Fever that persists over time without an apparent infection Night sweats and chills Fatigue and weakness Itching over large areas of the skin Symptoms related to affected organs, such as abdominal pain, coughing, or difficulty breathing
Diagnostic & Treatment
Diagnosis Path: Diagnosing non-follicular diffuse lymphoma involves a combination of medical assessments including physical examinations, imaging studies, and laboratory tests. Key steps include: - **Biopsy**: Removal of a tissue sample from a lymph node or involved organ for microscopic analysis - **Imaging tests**: PET scans, CT scans, or MRI to identify the extent and location of lymphoma spread - **Blood tests**: To evaluate overall health and look for markers associated with lymphoma - **Bone marrow biopsy**: To check if the disease has spread to the marrow - **Immunophenotyping and genetic studies**: To classify lymphoma subtypes and guide treatment options
Treatment Protocols: Treatment plans for non-follicular diffuse lymphoma often involve systemic therapies aimed at controlling or eliminating cancer cells. Common approaches include: - **Chemotherapy**: The primary treatment, using agents to kill or control lymphoma cells - **Targeted therapy**: Drugs designed to target specific molecules involved in lymphoma growth - **Radiation therapy**: Used in certain cases to target specific areas of disease - **Immunotherapy**: Treatments that help boost the body's immune response against lymphoma - **Stem cell transplantation**: In certain cases, especially when initial treatments are not effective, to restore healthy blood cell production The specific treatment approach depends on factors such as the disease stage, patient health, and response to initial therapy.
Clinical Advice & FAQs
Billing Guidance
Is C83.99 a billable ICD-10 code?
Yes, C83.99 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.99?
Clinical documentation must specify the nature of Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference